Prof Sean Hood

Experts / Prof Sean Hood

Psychiatrist; Head, University of Western Australia, Division of Psychiatry in the Medical School; Associate Dean, Faculty of Health and Medical Sciences

Prof Sean Hood is a psychiatrist in public and private practice. He is Head of the University of Western Australia, Division of Psychiatry in the Medical School, and Associate Dean with the Faculty of Health and Medical Sciences. Prof Hood’s primary research focus is in clinical psychopharmacology of anxiety disorders.

Agomelatine for the treatment of generalised anxiety disorder

In this Product Explainer, Psychiatrist Prof Sean Hood explains the role of the antidepressant agomelatine in the treatment of Generalised Anxiety Disorder (GAD) (5 mins).

Psychiatry

Podcasts

Anxiety – Management tips for primary care

How to manage the initial stages, when to transition from talk therapy to medication, how to initiate and manage medication regimes and what to do when first-line medications don’t seem to be working.

Anxiety – Management tips for primary care

How to manage the initial stages, when to transition from talk therapy to medication, how to initiate and manage medication regimes and what to do when first-line medications don’t seem to be working.

By Prof Sean Hood

Podcasts

Psychiatry

Agomelatine for the treatment of generalised anxiety disorder

In this Product Explainer, Psychiatrist Prof Sean Hood explains the role of the antidepressant agomelatine in the treatment of Generalised Anxiety Disorder (GAD) (5 mins).

By Prof Sean Hood

Videos

Psychiatry

Prof Sean Hood

Psychiatrist; Head, University of Western Australia, Division of Psychiatry in the Medical School; Associate Dean, Faculty of Health and Medical Sciences

More from this expert

Agomelatine for the treatment of generalised anxiety disorder

In this Product Explainer, Psychiatrist Prof Sean Hood explains the role of the antidepressant agomelatine in the treatment of Generalised Anxiety Disorder (GAD) (5 mins).

Anxiety – Management tips for primary care

How to manage the initial stages, when to transition from talk therapy to medication, how to initiate and manage medication regimes and what to do when first-line medications don’t seem to be working.

Anxiety – Management tips for primary care

How to manage the initial stages, when to transition from talk therapy to medication, how to initiate and manage medication regimes and what to do when first-line medications don’t seem to be working.

Agomelatine for the treatment of generalised anxiety disorder

In this Product Explainer, Psychiatrist Prof Sean Hood explains the role of the antidepressant agomelatine in the treatment of Generalised Anxiety Disorder (GAD) (5 mins).

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Prof Sean Hood

Psychiatrist; Head, University of Western Australia, Division of Psychiatry in the Medical School; Associate Dean, Faculty of Health and Medical Sciences

More from this expert

Agomelatine for the treatment of generalised anxiety disorder

In this Product Explainer, Psychiatrist Prof Sean Hood explains the role of the antidepressant agomelatine in the treatment of Generalised Anxiety Disorder (GAD) (5 mins).

Anxiety – Management tips for primary care

How to manage the initial stages, when to transition from talk therapy to medication, how to initiate and manage medication regimes and what to do when first-line medications don’t seem to be working.

Anxiety – Management tips for primary care

How to manage the initial stages, when to transition from talk therapy to medication, how to initiate and manage medication regimes and what to do when first-line medications don’t seem to be working.

Agomelatine for the treatment of generalised anxiety disorder

In this Product Explainer, Psychiatrist Prof Sean Hood explains the role of the antidepressant agomelatine in the treatment of Generalised Anxiety Disorder (GAD) (5 mins).

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.